Press Releases

May 21, 2024 – Methapharm Announces Partnership With Bosch Healthcare Solutions GmbH as the Distributor of the Newest FDA-Cleared FeNO Device, Vivatmo Pro, in the United States.

See News Release

April 15, 2024 – VVT Medical Ltd. appoints Methapharm as Distributor of ScleroSafe in the US

See News Release

December 1, 2023 – Methapharm appointed as Canadian distributor for KENGREXAL (cangrelor)

See News Release

November 16, 2023 – Methapharm appointed as Canadian distributor for RESOTRAN (prucalopride)

See News Release

June 5, 2023 – CHIESI appoints Methapharm as Canadian Distributor for CLEVIPREX® (clevidipine)

See News Release

April 7, 2022 – Methapharm to present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

See News Release

February 1, 2022 – Methapharm appointed US marketer for ASCLERA®

See News Release

December 24, 2021 – Methapharm expands diagnostic imaging collaboration to include technical service for contract media injectors

See News Release

July 29, 2020 - New Partnership to Offer Ready-To-Use Sterile Methacholine Solution Kits

See News Release

July 14, 2020 - Methapharm launches PEYONA® in Canada for use in Neonatal Intensive Care Units

See News Release

June 29, 2020 - Methapharm is pleased to announce that it has been appointed the Canadian distributor for SALAGEN® (Pilocarpine Hydrochloride Tablets).

See News Release

November 27, 2019 - Methapharm announces Canadian launch of ARIDOL® (mannitol inhalation powder).

See Press Release

April 22, 2019 – Methapharm to present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

See Press Release

February 4, 2019 – Methapharm announces development agreement with Biointerfaces Institute of McMaster University

See Press Release

December 13, 2018 - Methapharm announces US launch of ARIDOL® (mannitol inhalation powder)

See Press Release

November 8, 2018 - Methapharm Inc. announces participation in Triumvira Immunologics Inc. Convertible Debenture

See Press Release

September 18, 2017 - Adienne SA appoints Methapharm as Canadian distributor for TEPADINA (Thiotepa for injection, BP)

See Press Release

February 1, 2017 - Guerbet, the global specialist in contrast agents and solutions for medical imaging, announced that Methapharm will promote and distribute all Guerbet products in Canada

See Press Release

December 19, 2016 - Methapharm launches CUROSURF in Canada

See Press Release

April 13, 2016 - Methapharm is pleased to announce that it has been appointed the Canadian distributor for the Naprosyn, Anaprox, and Toradol brands

See Press Release

March 21, 2016 - SERB SA appoints Methapharm as Canadian distributor for CYANOKIT.

Press Release

May 20, 2014 - Methapharm Appointed as Canadian Distributor of Fucithalmic Viscous Eye Drops

See Press Release

March 24, 2014 - Methapharm is pleased to announce it has been appointed as the Canadian distributor for Lipiodol and Patent Blue V
April 4, 2013 - Methapharm is pleased to announce that it has successfully passed inspections from the State of Florida’s Division of Drugs, Devices and Cosmetics.

See Press Release

May 4, 2009 - Methapharm appointed Canadian distributor for Erythrocin IV

See Press Release

October 21, 2008 - Methapharm implements Axway’s Synchrony ePedigree solution.

See Press Release

March 19, 2008 - Methapharm implements Lorenz docuBridge®eCTD solution.

See Press Release

October 1, 2007 - Methapharm receives VAWD® accreditation from NABP®.

See Press Release

September 2006 - Methapharm Opens New European Affiliate Office
February 19, 2004 - Methapharm Opens New Canadian Distribution Centre